Ratings & Reviews performance provides an overview of what users think of your app. Here are the key metrics to help you identify how your app is rated by users and how successful is your review management strategy.
2.0
User reviews affect conversion to installs and app rating. Featured and helpful reviews are the first to be noticed by users and in case of no response can affect download rate.
Buy IBM Micromedex® NeoFax today for only $29.99 USD per year. You will be prompted to purchase the app after your initial download. If your institution already subscribes to IBM Micromedex® NeoFax® then this app is FREE. IBM Micromedex NeoFax is a reliable resource for on-the-go access to evidence-based drug information to efficiently and safely manage drug therapy for neonatal patients. It allows clinicians to make accurate and more informed treatment decisions at the point of care, while minimizing errors in this vulnerable patient population. This neonatal-specific app has clinical value for doctors, nurses, and pharmacists. An internet connection is not required, allowing you to make decisions with confidence at anytime, from anywhere. IBM Micromedex® is a trusted source for neonatal drug dosing, based on the strict editorial policies and practices that have guided Micromedex for more than 30 years. Evidence-based, fully referenced neonatal-specific drug information enables clinicians to make informed treatment decisions. The drug monographs cover information including: dose, administration, uses, contraindications/precautions, adverse effects, monitoring, pharmacology, special considerations/preparation, solution- and drug-drug compatibility/incompatibility information, and references. This mobile app also includes a comprehensive enteral formulas component providing nutritional information for approximately 60 different neonatal and infant formulas, and human milk fortifiers. IBM Micromedex NeoFax drug information is intended for full-term babies up to 28 days of age (PNA) and preterm babies up to 44 weeks postmenstrual age (GA + PNA). Do you work at a facility that subscribes to IBM Micromedex® NeoFax®? Check with your Chief of Pediatrics, Director of Pediatrics, Director of the NICU, Directory of Pharmacy, Chief Medical Officer, Chief Nursing Officer, Medical Librarian, or anyone else at your facility responsible for clinical reference information. If you work at a facility that subscribes to IBM Micromedex® NeoFax®, FREE access to these apps requires a password. To obtain the IBM Micromedex NeoFax password contact support at https://www.ibm.com/support/home/pages/support-guide/?product=4592217
